Indivior (LON:INDV) Trading Down 19.6% – Time to Sell?

Indivior PLC (LON:INDV)’s stock price was down 19.6% during mid-day trading on Thursday . The company traded as low as GBX 548.71 ($6.93) and last traded at GBX 697.50 ($8.81). Approximately 2,765,005 shares changed hands during mid-day trading, an increase of 277% from the average daily volume of 733,828 shares. The stock had previously closed at GBX 868 ($10.97).

Analyst Ratings Changes

Separately, Jefferies Financial Group reaffirmed a “buy” rating and issued a GBX 1,800 ($22.74) target price on shares of Indivior in a research report on Tuesday, December 17th.

Indivior Trading Down 5.9 %

The firm has a 50 day moving average of GBX 920.11 and a 200-day moving average of GBX 850.81. The company has a quick ratio of 1.52, a current ratio of 0.83 and a debt-to-equity ratio of -170.06. The firm has a market capitalization of £1.08 billion, a P/E ratio of -570.87, a PEG ratio of -5.57 and a beta of 0.19.

Indivior Company Profile

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.